Biomarin Pharmaceutical Stock Technical Analysis

BMRN Stock  USD 87.34  1.27  1.43%   
As of the 29th of March, Biomarin Pharmaceutical shows the Standard Deviation of 1.32, mean deviation of 1.04, and Risk Adjusted Performance of (0.05). Biomarin Pharmaceutical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Biomarin Pharmaceutical, which can be compared to its rivals. Please confirm Biomarin Pharmaceutical variance and potential upside to decide if Biomarin Pharmaceutical is priced correctly, providing market reflects its regular price of 87.34 per share. Given that Biomarin Pharmaceutical has information ratio of (0.21), we suggest you to validate Biomarin Pharmaceutical's prevailing market performance to make sure the company can sustain itself at a future point.

Biomarin Pharmaceutical Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Biomarin, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Biomarin
  
Biomarin Pharmaceutical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Biomarin Pharmaceutical Analyst Consensus

Target PriceAdvice# of Analysts
116.95Strong Buy30Odds
Biomarin Pharmaceutical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Biomarin analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biomarin stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biomarin Pharmaceutical, talking to its executives and customers, or listening to Biomarin conference calls.
Biomarin Analyst Advice Details
Biomarin Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biomarin Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biomarin Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Biomarin Pharmaceutical Technical Analysis

Indicator
Time Period
Execute Indicator
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Biomarin Pharmaceutical volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Biomarin Pharmaceutical Trend Analysis

Use this graph to draw trend lines for Biomarin Pharmaceutical. You can use it to identify possible trend reversals for Biomarin Pharmaceutical as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Biomarin Pharmaceutical price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Biomarin Pharmaceutical Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Biomarin Pharmaceutical applied against its price change over selected period. The best fit line has a slop of   0.19  , which may suggest that Biomarin Pharmaceutical market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1417.83, which is the sum of squared deviations for the predicted Biomarin Pharmaceutical price change compared to its average price change.

About Biomarin Pharmaceutical Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Biomarin Pharmaceutical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Biomarin Pharmaceutical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Biomarin Pharmaceutical price pattern first instead of the macroeconomic environment surrounding Biomarin Pharmaceutical. By analyzing Biomarin Pharmaceutical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Biomarin Pharmaceutical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Biomarin Pharmaceutical specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2021 2022 2023 2024 (projected)
Dividend Yield2.1E-47.85E-49.03E-40.001663
Price To Sales Ratio8.759.157.497.11

Biomarin Pharmaceutical March 29, 2024 Technical Indicators

Most technical analysis of Biomarin help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Biomarin from various momentum indicators to cycle indicators. When you analyze Biomarin charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Biomarin Pharmaceutical March 29, 2024 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Biomarin stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Biomarin Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomarin Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomarin Pharmaceutical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomarin Pharmaceutical Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomarin Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Biomarin Stock analysis

When running Biomarin Pharmaceutical's price analysis, check to measure Biomarin Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomarin Pharmaceutical is operating at the current time. Most of Biomarin Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biomarin Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomarin Pharmaceutical's price. Additionally, you may evaluate how the addition of Biomarin Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Biomarin Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomarin Pharmaceutical. If investors know Biomarin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomarin Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.98
Earnings Share
0.87
Revenue Per Share
12.88
Quarterly Revenue Growth
0.202
Return On Assets
0.0163
The market value of Biomarin Pharmaceutical is measured differently than its book value, which is the value of Biomarin that is recorded on the company's balance sheet. Investors also form their own opinion of Biomarin Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biomarin Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomarin Pharmaceutical's market value can be influenced by many factors that don't directly affect Biomarin Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomarin Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomarin Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomarin Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.